Dec 06, 2018
ZAXINE® (rifaximin) - Now Indicated in Canada for Patients with Irritable Bowel Syndrome with Diarrhea (IBS-D)1,2
Dec 05, 2018
IFFGD Marks Constipation Awareness Month with Launch of Education Campaign
Nov 13, 2018
Ardelyx Announces FDA Acceptance of the Filing of its New Drug Application for Tenapanor for the Treatment of Patients with IBS-C
Nov 08, 2018
For The Fourth Year In A Row, U.S. Gastroenterologists Endorse Clinically Studied, Nonprescription IBS Product, IBgard®, By An Overwhelming Margin
Oct 08, 2018
Ardelyx Showcases New Data from T3MPO-3 Long-Term Safety Trial of Tenapanor for IBS-C in Presidential Poster at ACG 2018 Annual Meeting
Oct 08, 2018
Allergan Presents New Research at the American College of Gastroenterology Annual Scientific Meeting (ACG 2018)
Sep 13, 2018
Ardelyx Submits New Drug Application for U.S. Marketing Authorization of Tenapanor for IBS-C to U.S. Food and Drug Administration
Sep 06, 2018
Salix Pharmaceuticals To Present Clinical Data For The Treatment Of Opioid-Induced Constipation At 2018 PAINWeek Conference
Sep 05, 2018
Global chronic idiopathic constipation (CIC) drug market is estimated to grow at a CAGR of 8.42% during the forecast period of 2018-2026
May 01, 2018
Allergan and Ironwood Launch Interactive Digital Destination During Irritable Bowel Syndrome (IBS) Awareness Month Designed to Encourage Sufferers to Get Educated and Take Action
Apr 17, 2018
Health Canada Grants Atrantil A Natural Health Product Number
Apr 02, 2018
Social Taboos, Lack of Awareness May Prevent Diagnosis and Treatment of IBS
Jan 03, 2018
Ardelyx Successfully Completes T3MPO-3 Safety Extension Study of Tenapanor for IBS-C
Dec 26, 2017
Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
Oct 20, 2017
Veterans Affairs Federal Supply Service Supplier Now Has a Mini-Enema Available for Children
Oct 16, 2017
Ardelyx Announces Tenapanor Reduces Pain Caused by IBS-C Through Inhibition of TRPV-1 Signaling
Oct 16, 2017
Allergan to Present New Data at the World Congress of Gastroenterology at ACG 2017
Oct 12, 2017
Colorectal Cancer Drug Development Pipeline Review, 2017
Oct 11, 2017
Ardelyx's Pivotal Phase 3 Study of Tenapanor for IBS-C Hits Primary and All Secondary Endpoints to Support NDA Submission in 2018
Oct 04, 2017
Vibrant Successfully Completes Two Clinical Studies Showcasing the Efficacy of World's First Vibrating Capsule to Treat Chronic Constipation